Skip to main content

NANOMIX Corp

NNMXDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001473579

NANOMIX Corp was delisted in 2022; its insiders filed their last Form 4 on Dec 21, 2022; no institution reported holding it in 13F filings for Q3 2022; no superinvestor held it.

Holders of 5% or more of NNMX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of NANOMIX Corp, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of NANOMIX Corp on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on NANOMIX Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NNMX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 8, 2024Hudson Bay Capital Management LP13G/AOld format–––SEC
Feb 6, 2024Hudson Bay Capital Management LP13G/AOld format–––SEC
Feb 10, 2023Hudson Bay Capital Management LP13G/AOld format–––SEC
Feb 7, 2022Hudson Bay Capital Management LP13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell NANOMIX Corp shares.

No Form 144 notices for NANOMIX Corp are on file.